{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T05:23:02Z","timestamp":1787376182429,"version":"build-2736575974"},"reference-count":35,"publisher":"Tohoku University Medical Press","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.1620\/tjem.2025.j069","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:08:04Z","timestamp":1749060484000},"page":"323-331","source":"Crossref","is-referenced-by-count":0,"title":["Brain-Derived Neurotrophic Factor is Negatively Associated with Anxiety and Depression in Psoriasis Patients"],"prefix":"10.1620","volume":"269","author":[{"given":"Bo","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Huashan Hospital, Shanghai Medical College, Fudan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manzhao","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Handan Hospital of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixi","family":"Cuomu","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, People\u2019s Hospital of Tibet Autonomous Region"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Shanghai Children\u2019s Medical Center, Jiao Tong University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"Armstrong, A.W., Bohannan, B., Mburu, S., Coates, L.C., Ogdie, A., Alarcon, I., Kasparek, T., Frade, S., Barrio, S.F.&Augustin, M. (2023) Patient Perspectives on Psoriatic Disease Burden: Results from the Global Psoriasis and Beyond Survey. Dermatology<\/i>, 239, 621-634. https:\/\/doi.org\/10.1159\/000528945","DOI":"10.1159\/000528945"},{"key":"2","doi-asserted-by":"publisher","unstructured":"Badaiki, W., Penney, M., Pyper, E., Lester, K., Skeard, J., Shin, J., Fisher, B., Gulliver, S., Gulliver, W.&Rahman, P. (2022) Real World Studies of Psoriasis and Mental Illness in Newfoundland and Labrador. J. Cutan. Med. Surg.<\/i>, 26, 494-501. https:\/\/doi.org\/10.1177\/12034754221117736","DOI":"10.1177\/12034754221117736"},{"key":"3","doi-asserted-by":"publisher","unstructured":"Balak, D.M.&Hajdarbegovic, E. (2017) Drug-induced psoriasis: clinical perspectives. Psoriasis<\/i> (Auckl.<\/i>), 7, 87-94. https:\/\/doi.org\/10.2147\/PTT.S126727","DOI":"10.2147\/PTT.S126727"},{"key":"4","doi-asserted-by":"publisher","unstructured":"Brahimi, F., Galan, A., Siegel, S., Szobota, S., Sarunic, M.V., Foster, A.C.&Saragovi, H.U. (2021) Therapeutic Neuroprotection by an Engineered Neurotrophin that Selectively Activates Tropomyosin Receptor Kinase (Trk) Family Neurotrophin Receptors but Not the p75 Neurotrophin Receptor. Mol. Pharmacol.<\/i>, 100, 491-501. https:\/\/doi.org\/10.1124\/molpharm.121.000301","DOI":"10.1124\/molpharm.121.000301"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Brunoni, A.R., Lotufo, P.A., Sabbag, C., Goulart, A.C., Santos, I.S.&Bensenor, I.M. (2015) Decreased brain-derived neurotrophic factor plasma levels in psoriasis patients. Braz. J. Med. Biol. Res.<\/i>, 48, 711-714. https:\/\/doi.org\/10.1590\/1414-431X20154574","DOI":"10.1590\/1414-431x20154574"},{"key":"6","doi-asserted-by":"publisher","unstructured":"Cortes, H., Rojas-Marquez, M., Del Prado-Audelo, M.L., Reyes-Hernandez, O.D., Gonzalez-Del Carmen, M.&Leyva-Gomez, G. (2022) Alterations in mental health and quality of life in patients with skin disorders: a narrative review. Int. J. Dermatol.<\/i>, 61, 783-791. https:\/\/doi.org\/10.1111\/ijd.15852","DOI":"10.1111\/ijd.15852"},{"key":"7","doi-asserted-by":"publisher","unstructured":"Dong, B.E., Chen, H.&Sakata, K. (2020) BDNF deficiency and enriched environment treatment affect neurotransmitter gene expression differently across ages. J. Neurochem.<\/i>, 154, 41-55. https:\/\/doi.org\/10.1111\/jnc.15017","DOI":"10.1111\/jnc.15017"},{"key":"8","doi-asserted-by":"publisher","unstructured":"Dou, S.H., Cui, Y., Huang, S.M.&Zhang, B. (2022) The Role of Brain-Derived Neurotrophic Factor Signaling in Central Nervous System Disease Pathogenesis. Front. Hum. Neurosci.<\/i>, 16, 924155. https:\/\/doi.org\/10.3389\/fnhum.2022.924155","DOI":"10.3389\/fnhum.2022.924155"},{"key":"9","doi-asserted-by":"publisher","unstructured":"Efffendy, E., Sjahrir, M.&Utami, N. (2021) The Relationship between Brain-derived Neurotrophic Factor\u2019s Serum Level and Hospital Anxiety and Depression Scale-depression in Patients with Psoriasis Vulgaris. Open Access Maced. J. Med. Sci.<\/i>, 9, 164-167. https:\/\/doi.org\/10.3889\/oamjms.2021.6290","DOI":"10.3889\/oamjms.2021.6290"},{"key":"10","doi-asserted-by":"publisher","unstructured":"Griffiths, C.E.M., Armstrong, A.W., Gudjonsson, J.E.&Barker, J. (2021) Psoriasis. Lancet<\/i>, 397, 1301-1315. https:\/\/doi.org\/10.1016\/S0140-6736(20)32549-6","DOI":"10.1016\/S0140-6736(20)32549-6"},{"key":"11","doi-asserted-by":"publisher","unstructured":"Hisaoka-Nakashima, K., Taki, S., Watanabe, S., Nakamura, Y., Nakata, Y.&Morioka, N. (2019) Mirtazapine increases glial cell line-derived neurotrophic factor production through lysophosphatidic acid 1 receptor-mediated extracellular signal-regulated kinase signaling in astrocytes. Eur. J. Pharmacol.<\/i>, 860, 172539. https:\/\/doi.org\/10.1016\/j.ejphar.2019.172539","DOI":"10.1016\/j.ejphar.2019.172539"},{"key":"12","doi-asserted-by":"publisher","unstructured":"Jalenques, I., Bourlot, F., Martinez, E., Pereira, B., D'Incan, M., Lauron, S.&Rondepierre, F. (2022) Prevalence and Odds of Anxiety Disorders and Anxiety Symptoms in Children and Adults with Psoriasis: Systematic Review and Meta-analysis. Acta Derm. Venereol.<\/i>, 102, adv00769. https:\/\/doi.org\/10.2340\/actadv.v102.1386","DOI":"10.2340\/actadv.v102.1386"},{"key":"13","doi-asserted-by":"publisher","unstructured":"Jeng, Y.C., Lin, Y.C., Hsu, C.K., Lee, J.Y.&Lee, C.N. (2023) Generalized pustular psoriasis caused by bupropion with rapid recurrence after self-rechallenge. Exp. Dermatol.<\/i>, 32, 1306-1307. https:\/\/doi.org\/10.1111\/exd.14838","DOI":"10.1111\/exd.14838"},{"key":"14","doi-asserted-by":"publisher","unstructured":"JiaWen, W., Hong, S., ShengXiang, X.&Jing, L. (2018) Depression- and anxiety-like behaviour is related to BDNF\/TrkB signalling in a mouse model of psoriasis. Clin. Exp. Dermatol.<\/i>, 43, 254-261. https:\/\/doi.org\/10.1111\/ced.13378","DOI":"10.1111\/ced.13378"},{"key":"15","doi-asserted-by":"publisher","unstructured":"Kluger, N.(2023) Psoriasis exacerbation associated with bupropion-induced exanthema. Ann. Dermatol. Venereol.<\/i>, 150, 73-75. https:\/\/doi.org\/10.1016\/j.annder.2022.09.003","DOI":"10.1016\/j.annder.2022.09.003"},{"key":"16","doi-asserted-by":"publisher","unstructured":"Kouris, A., Platsidaki, E., Kouskoukis, C.&Christodoulou, C. (2017) Psychological parameters of psoriasis. Psychiatriki.<\/i>, 28, 54-59. https:\/\/doi.org\/10.22365\/jpsych.2017.281.54","DOI":"10.22365\/jpsych.2017.281.54"},{"key":"17","doi-asserted-by":"publisher","unstructured":"Li, Y., Li, F., Qin, D., Chen, H., Wang, J., Wang, J., Song, S., Wang, C., Wang, Y., Liu, S., Gao, D.&Wang, Z.H. (2022) The role of brain derived neurotrophic factor in central nervous system. Front. Aging Neurosci.<\/i>, 14, 986443. https:\/\/doi.org\/10.3389\/fnagi.2022.986443","DOI":"10.3389\/fnagi.2022.986443"},{"key":"18","doi-asserted-by":"publisher","unstructured":"Martinez-Ortega, J.M., Nogueras, P., Munoz-Negro, J.E., Gutierrez-Rojas, L., Gonzalez-Domenech, P.&Gurpegui, M. (2019) Quality of life, anxiety and depressive symptoms in patients with psoriasis: A case-control study. J. Psychosom. Res.<\/i>, 124, 109780. https:\/\/doi.org\/10.1016\/j.jpsychores.2019.109780","DOI":"10.1016\/j.jpsychores.2019.109780"},{"key":"19","doi-asserted-by":"publisher","unstructured":"Mathur, A., Neema, S., Sahu, R.&Radhakrishnan, S. (2023) Anxiety, depression and harmful use of alcohol in severe chronic plaque psoriasis: A cross-sectional study. Med. J. Armed Forces India<\/i>, 79, 464-469. https:\/\/doi.org\/10.1016\/j.mjafi.2020.10.014","DOI":"10.1016\/j.mjafi.2020.10.014"},{"key":"20","doi-asserted-by":"publisher","unstructured":"Merabtine, T., Tarhini, Z., Preux, P.M., Christou, N.&Jost, J. (2024) Effects of antidepressant and antipsychotic medication on peripheral brain-derived neurotrophic factor concentration: Systematic review and meta-analysis. Psychiatry Res.<\/i>, 337, 115946. https:\/\/doi.org\/10.1016\/j.psychres.2024.115946","DOI":"10.1016\/j.psychres.2024.115946"},{"key":"21","doi-asserted-by":"publisher","unstructured":"Pandey, S.C., Zhang, H., Roy, A.&Misra, K. (2006) Central and medial amygdaloid brain-derived neurotrophic factor signaling plays a critical role in alcohol-drinking and anxiety-like behaviors. J. Neurosci.<\/i>, 26, 8320-8331. https:\/\/doi.org\/10.1523\/JNEUROSCI.4988-05.2006","DOI":"10.1523\/JNEUROSCI.4988-05.2006"},{"key":"22","doi-asserted-by":"publisher","unstructured":"Pollo, C.F., Miot, H.A., Matos, T.D.S., de Souza, J.M., Jorge, M.F.S., Miot, L.D.B.&Meneguin, S. (2021) Prevalence and factors associated with depression and anxiety in patients with psoriasis. J. Clin. Nurs.<\/i>, 30, 572-580. https:\/\/doi.org\/10.1111\/jocn.15577","DOI":"10.1111\/jocn.15577"},{"key":"23","doi-asserted-by":"publisher","unstructured":"Porter, G.A.&O\u2019Connor, J.C. (2022) Brain-derived neurotrophic factor and inflammation in depression: Pathogenic partners in crime? World J. Psychiatry<\/i>, 12, 77-97. https:\/\/doi.org\/10.5498\/wjp.v12.i1.77","DOI":"10.5498\/wjp.v12.i1.77"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Quinto, R.M., De Vincenzo, F., Graceffa, D., Bonifati, C., Innamorati, M.&Iani, L. (2022) The Relationship between Alexithymia and Mental Health Is Fully Mediated by Anxiety and Depression in Patients with Psoriasis. Int. J. Environ. Res. Public Health<\/i>, 19, 3649. https:\/\/doi.org\/10.3390\/ijerph19063649","DOI":"10.3390\/ijerph19063649"},{"key":"25","doi-asserted-by":"publisher","unstructured":"Rafa-Zablocka, K., Kreiner, G., Baginska, M.&Nalepa, I. (2018) Selective Depletion of CREB in Serotonergic Neurons Affects the Upregulation of Brain-Derived Neurotrophic Factor Evoked by Chronic Fluoxetine Treatment. Front. Neurosci.<\/i>, 12, 637. https:\/\/doi.org\/10.3389\/fnins.2018.00637","DOI":"10.3389\/fnins.2018.00637"},{"key":"26","doi-asserted-by":"publisher","unstructured":"Raharja, A., Mahil, S.K.&Barker, J.N. (2021) Psoriasis: a brief overview. Clin. Med.<\/i> (Lond.<\/i>), 21, 170-173. https:\/\/doi.org\/10.7861\/clinmed.2021-0257","DOI":"10.7861\/clinmed.2021-0257"},{"key":"27","doi-asserted-by":"publisher","unstructured":"Sbidian, E., Chaimani, A., Guelimi, R., Garcia-Doval, I., Hua, C., Hughes, C., Naldi, L., Kinberger, M., Afach, S.&Le Cleach, L. (2023) Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database Syst. Rev.<\/i>, 7, CD011535. https:\/\/doi.org\/10.1002\/14651858.CD011535.pub3","DOI":"10.1002\/14651858.CD011535.pub3"},{"key":"28","doi-asserted-by":"publisher","unstructured":"Sjahrir, M., Roesyanto-Mahadi, I.D.&Effendy, E. (2019) Correlation between Serum Brain-Derived Neurotrophic Factor Level and Depression Severity in Psoriasis Vulgaris Patients. Open Access Maced. J. Med. Sci.<\/i>, 7, 583-586. https:\/\/doi.org\/10.3889\/oamjms.2019.142","DOI":"10.3889\/oamjms.2019.142"},{"key":"29","doi-asserted-by":"publisher","unstructured":"Sutaria, N.&Au, S.C. (2021) Failure rates and survival times of systemic and biologic therapies in treating psoriasis: a retrospective study. J. Dermatolog. Treat.<\/i>, 32, 617-620. https:\/\/doi.org\/10.1080\/09546634.2019.1688756","DOI":"10.1080\/09546634.2019.1688756"},{"key":"30","doi-asserted-by":"publisher","unstructured":"Tamer, E., Gur, G., Polat, M.&Alli, N. (2009) Flare-up of pustular psoriasis with fluoxetine: possibility of a serotoninergic influence? J. Dermatolog. Treat.<\/i>, 20, 1-3. https:\/\/doi.org\/10.1080\/09546630802449096","DOI":"10.1080\/09546630802449096"},{"key":"31","doi-asserted-by":"publisher","unstructured":"Tan Pei Lin, L.&Kwek, S.K. (2010) Onset of psoriasis during therapy with fluoxetine. Gen. Hosp. Psychiatry<\/i>, 32, 446 e449-446 e410. https:\/\/doi.org\/10.1016\/j.genhosppsych.2009.08.008","DOI":"10.1016\/j.genhosppsych.2009.08.008"},{"key":"32","doi-asserted-by":"publisher","unstructured":"Timis, T.L., Beni, L., Mocan, T., Florian, I.A.&Orasan, R.I. (2023) Biologic Therapies Decrease Disease Severity and Improve Depression and Anxiety Symptoms in Psoriasis Patients. Life<\/i> (Basel<\/i>), 13, 1219. https:\/\/doi.org\/10.3390\/life13051219","DOI":"10.3390\/life13051219"},{"key":"33","doi-asserted-by":"publisher","unstructured":"Toricelli, M., Pereira, A.A.R., Souza Abrao, G., Malerba, H.N., Maia, J., Buck, H.S.&Viel, T.A. (2021) Mechanisms of neuroplasticity and brain degeneration: strategies for protection during the aging process. Neural Regen. Res.<\/i>, 16, 58-67. https:\/\/doi.org\/10.4103\/1673-5374.286952","DOI":"10.4103\/1673-5374.286952"},{"key":"34","doi-asserted-by":"publisher","unstructured":"Truzzi, F., Marconi, A., Atzei, P., Panza, M.C., Lotti, R., Dallaglio, K., Tiberio, R., Palazzo, E., Vaschieri, C.&Pincelli, C. (2011) p75 neurotrophin receptor mediates apoptosis in transit-amplifying cells and its overexpression restores cell death in psoriatic keratinocytes. Cell Death Differ.<\/i>, 18, 948-958. https:\/\/doi.org\/10.1038\/cdd.2010.162","DOI":"10.1038\/cdd.2010.162"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Zigmond, A.S.&Snaith, R.P. (1983) The hospital anxiety and depression scale. Acta Psychiatr. Scand.<\/i>, 67, 361-370. https:\/\/doi.org\/10.1111\/j.1600-0447.1983.tb09716.x","DOI":"10.1111\/j.1600-0447.1983.tb09716.x"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/269\/3\/269_2025.J069\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T04:25:28Z","timestamp":1787372728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/269\/3\/269_2025.J069\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2025.j069","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"2025.J069"}}